3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
41
Carcinoma, Renal Cell
31
Neoplasms
18
Kidney Neoplasms
17
Neuroendocrine Tumors
16
Neoplasm Metastasis
13
Tuberous Sclerosis
10
Prostatic Neoplasms
8
Carcinoma
8
Lymphoma, Mantle-Cell
7
Lymphoma, Large B-Cell, Diffuse
7
Hodgkin Disease
7
Glioma
7
Glioblastoma
7
Astrocytoma
7
Waldenstrom Macroglobulinemia
6
Triple Negative Breast Neoplasms
6
Recurrence
6
Lymphoma
6
Head and Neck Neoplasms
6
Stomach Neoplasms
5
Ovarian Neoplasms
5
Colorectal Neoplasms
5
Carcinoma, Neuroendocrine
5
Brain Neoplasms
5
Sezary Syndrome
4
Sarcoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Mycosis Fungoides
4
Interventions
Nivolumab
11
Ipilimumab
6
linrodostat
4
relatlimab
3
Pemetrexed
2
tislelizumab
1
regorafenib
1
ralimetinib
1
p38 Mitogen-Activated Protein Kinases
1
mirdametinib
1
gedatolisib
1
figitumumab
1
efatutazone
1
abemaciclib
1
Vorinostat
1
Tetanus Toxoid
1
Tamoxifen
1
Sunitinib
1
Ranitidine
1
Midazolam
1
LY2603618
1
LY2584702
1
Irinotecan
1
Gemcitabine
1
Fulvestrant
1
Dasatinib
1
Cyclophosphamide
1
Crizotinib
1
Cetuximab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Cancer
×
Everolimus
×
Clear all
No trials found.